3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
12
Phase 1/2
7
Phase 1
4
Phase NA
2
Phase EARLY_PHASE1
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
1041
Neoplasms
872
Prostatic Neoplasms
506
Lung Neoplasms
421
Colorectal Neoplasms
357
Motor Activity
219
Head and Neck Neoplasms
194
Uterine Cervical Neoplasms
189
Carcinoma, Non-Small-Cell Lung
180
Brain Neoplasms
173
Pancreatic Neoplasms
160
Ovarian Neoplasms
138
Colonic Neoplasms
137
Carcinoma, Hepatocellular
136
Anxiety Disorders
124
Rectal Neoplasms
117
Hematologic Neoplasms
114
Multiple Myeloma
106
Stomach Neoplasms
103
Neoplasm Metastasis
99
Precursor Cell Lymphoblastic Leukemia-Lymphoma
94
Melanoma
92
Depression
92
Urinary Bladder Neoplasms
88
Pain
87
Endometrial Neoplasms
86
Glioblastoma
84
Disease
83
Lymphoma
81
Sarcoma
78
Interventions
camrelizumab
1
Colonoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Turcot syndrome
×
1 year
×
Clear all
NCT07360834
2026-01-23
PREDI-LYNCH
UNICANCER
Phase NA
Not yet recruiting
2,000 enrolled
NCT06215677
2025-09-05
NITDC
Peking Union Medical College Hospital
Phase NA
Recruiting
18 enrolled